ABCL
AbCellera Biologics Inc. · Healthcare · Market cap $3.8B
Insiders bought $1.5M net in the last 90 days ·0 sellers, 3 buyers· latest Form 4 filed Aug 24, 2026
Insider Buying
$2.7M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Aug 24, 2026
Hayden Michael R
AbCellera Biologics Inc. (ABCL) has 12 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Aug 24, 2026.
Inside the rolling window, 4 insiders at AbCellera Biologics Inc. reported 9 open-market purchases totaling $2.7M and no open-market sales. The most active filer is Director Montalbano John S. with 3 filings. Insiders have net bought $2.5M over the trailing 6 months. The most recent open-market filing is a purchase of 53,613 shares by Director Hayden Michael R, dated Aug 24, 2026, worth $570K.
- Industry:Biotechnology
- CEO:Carl Hansen
- Employees:562
- HQ:Vancouver, BC, CA
- IPO:2020-12-11
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Director | Purchase | 53,613 | $570K | Aug 24 | +15.4% | SEC ↗ | |
Montalbano John S.First in 3 months | Director | Purchase | 10,000 | $110K | Aug 18 | +10.1% | SEC ↗ |
| Director | Purchase | 46,387 | $481K | Aug 14 | +7.6% | SEC ↗ | |
Booth AndrewFirst in 6 months | Chief Financial Officer | Purchase | 37,200 | $384K | Aug 14 | +7.6% | SEC ↗ |
Montalbano John S.First in 6 months | Director | Purchase | 20,000 | $95K | May 18 | +194.2% | SEC ↗ |
| 10% Owner | Purchase | 38,000 | $131K | Mar 2 | +220.4% | SEC ↗ | |
Thermopylae Holdings Ltd.First filing | 10% Owner | Purchase | 177,457 | $580K | Feb 27 | +239.1% | SEC ↗ |
Booth AndrewFirst filing | Chief Financial Officer | Purchase | 42,600 | $146K | Feb 27 | +239.1% | SEC ↗ |
Montalbano John S.First filing | Director | Purchase | 50,000 | $178K | Nov 26 | +236.3% | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ABCL have?
AbCellera Biologics Inc. (ABCL) has 12 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for ABCL?
The most recent Form 4 filing for ABCL on Tracefour is dated Aug 24, 2026.
Who is the most active insider at ABCL?
The most active SEC Form 4 filer at ABCL in the rolling window is Director Montalbano John S., with 3 filings.
What is the net insider flow at ABCL over the last 6 months?
Over the trailing 180 days, insiders at ABCL have net bought $2.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ABCL in the current window?
Inside the rolling window, insiders at ABCL bought $2.7M and sold $0 based on SEC Form 4 filings.
Can I get alerts for ABCL insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at AbCellera Biologics Inc. (ABCL). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
AbCellera Biologics Inc. is in the Healthcare sector.